NCCN Guidelines Version 2.2024
- Ductal Carcinoma in situ (DCIS)
- Invasive Breast Cancer
- Special consideration: Breast Cancer During Pregnancy
- Special consideration: Inflammatory Breast Cancer
- Special consideration: Paget Disease
- Special consideration: Phyllodes Tumor
Basic Resources (English) Version 4.2022
Core Resources (English) Version 4.2022
Enhanced Resources (English) Version 4.2022
Invasive Breast Cancer-English Version 2023
Metastatic Breast Cancer-English Version 2023
Ductal Carcinoma In Situ-English Version 2024
Inflammatory Breast Cancer-English Version 2023
Ductal Carcinoma In Situ-Spanish - Latin America Version 2023
Metastatic Breast Cancer-Spanish - Latin America Version 2023
Invasive Breast Cancer-Spanish - Latin America Version 2023
Inflammatory Breast Cancer-Spanish - Latin America Version 2023
Continuing Education
NCCN Guidelines® Insights - Breast Cancer Screening and Diagnosis, Version 1.2023
Recognizing Bias and Health Care Disparities in Black Patients
Comorbidities, Dosing Issues, Polypharmacy, and Adverse Effects in Breast Cancer
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates
Advances in the Management of Metastatic Breast Cancer with SABCS Updates
Issues with Sexuality and Sexual Function in Patients with Breast Cancer
Translations
Chinese Version 4.2022
French Version 8.2021
Italian Version 2.2022
Spanish Version 2.2022
Ukrainian Version 2.2022
Adaptations
English (Middle East & North Africa) Version 2.2023
English (European/Poland) Version 4.2023
Harmonized
English (Africa) Version 4.2021